# 4D Molecular Therapeutics, Inc.: Form DEF 14A, filed Apr 6, 2021

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: DEF 14A
- Filed: 2021-04-06
- Accepted by EDGAR: Apr 6, 2021, 17:22 ET
- Period: 2021-05-17
- Accession: 0001193125-21-107762
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312521107762/d155968ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312521107762/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312521107762/d155968ddef14a.htm

Filed Apr 6, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-107762. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.
